ROIVANT SCIENCES LTD. (ROIV)

SEC filing

ROIVANT SCIENCES LTD.

ROIV · CIK 1635088

4 · Dec 31, 2025 · Sukhatme Mayukh sold 1.33M shares at $21.72/share ($28.9M); exercised options for 3.20M shares; reported 1.87M shares

Sukhatme Mayukh sold 1.33M shares at $21.72/share ($28.9M); exercised options for 3.20M shares; reported 1.87M shares

FORM 4

xslF345X05/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).